Clinical Trial Update: Genetic Testing in Guiding Treatment for Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 study evaluating whether genetic testing can guide treatment for patients with brain metastases; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: CDK Gene Mutation, Metastatic Malignant Neoplasm in the Brain | Phase 2 | Status: ACTIVE_NOT_RECRUITING